FDA Approval Activities for this Drug…

Ditropan XL Tablets, Syrup & Extended Release Tablets, 5 mg, 10 mg Johnson & Johnson Pharmaceutical NDA 17-577/S33, S32, 18-211/S16, S14 & 20-897/S9, S10 4/15/03 4/16/03 Ditropan XL Tablets, 5 mg, 10 mg Alza NDA 20-897 12/16 12/18 12/17 7/8/99 Ditropan XL Indication: Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

For the latest approval information, please locate this drug using this index.